While elevated levels of TGF-β and its receptors have been well documented in the context of hypertension and an HFD [64,65], the regulatory mechanisms controlling the inhibitory components of this signaling pathway are less well understood. This evidence concerns the gene TGFB1 and hypertensive disorder.